Biostax Corp (BTAX)

[noreen]

In the meantime, based on the information in the filings, all this valuable time has passed wherein a product could have already been or very near to approval for narketing by the FDA. What is management's explanation(s) for this-does anyone know?

As bpammy said, and I've said before, Cytocom is a private company. How do you know they've "let 4 years pass since a productive meeting"? My guess is they have not let 4 years pass since productivity, but we don't know yet, because it is a private company.

Are we entitled to more information than we've got so far? Not that I'm aware of. Do you know any differently?

2 things that lead me to believe that Cytocom HAS made tons of progress, but has just not told IMUN shareholders YET...

1. In 2014, when the spinoff occurred, IMUN did own a majority 55% of Cytocom. So basically, we haven't received a single update since the spinoff, and we're not entitled to from my understanding. And NOW, IMUN only owns 11-12%. I'm just going to guess with that kind of dilution, some progress has been made. Just a guess.

2. Quote from 3/17/17 8-k/a..

https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11939370

Following Launch of Lodonal, Management to Provide Greater Detail Over Pipeline of its Various Drugs in the Approval Process both with the FDA and Internationally

That tells me they've made progress, aren't legally required to update us yet (since Cytocom is private), and will let IMUN shareholders know when THEY ARE READY to promote the company. Pretty obvious they don't want to promote it yet. Which makes sense I guess - still no purchase orders.